10-Q Filing

GUIDED THERAPEUTICS INC CIK: 924515 Q3 2015

Filing Information

Form Type	10-Q
Accession Number	`0001121781-15-000315`
Period End Date	20150930
Filing Date	20151112
Fiscal Year	2015
Fiscal Period	Q3
XBRL Instance	gthp-20150930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 92 Income Statement 80 Cash Flow Statement 82

Balance Sheet 92 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$162.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$172.00K	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$63.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$42.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$613.00K	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$76.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $63 and $76 at September 30, 2015 and December 31, 2014, respectively	`AccountsReceivableNet`	$219.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$97.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$144.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $63 and $76 at September 30, 2015 and December 31, 2014, respectively	`AccountsReceivableNet`	$338.00K	USD	Point-in-time
Inventory, net of reserves of $97 and $144, at September 30, 2015 and December 31, 2014, respectively	`InventoryNet`	$912.00K	USD	Point-in-time
Inventory, net of reserves of $97 and $144, at September 30, 2015 and December 31, 2014, respectively	`InventoryNet`	$1.18M	USD	Point-in-time
Series B convertible preferred stock par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$979.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$99.00K	USD	Point-in-time
Series B convertible preferred stock par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.78M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.28M	USD	Point-in-time
Series B convertible preferred stock shares authorized	`PreferredStockSharesAuthorized`	3.00	shares	Point-in-time
Series B convertible preferred stock shares authorized	`PreferredStockSharesAuthorized`	3.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$377.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$587.00K	USD	Point-in-time
Series B convertible preferred stock, Issued	`PreferredStockSharesIssued`	1.20	shares	Point-in-time
Series B convertible preferred stock, Issued	`PreferredStockSharesIssued`	1.20	shares	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$108.00K	USD	Point-in-time
Series B convertible preferred stock, Outstanding	`PreferredStockSharesOutstanding`	1.20	shares	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$101.00K	USD	Point-in-time
Series B convertible preferred stock, Outstanding	`PreferredStockSharesOutstanding`	1.20	shares	Point-in-time
Debt issuance costs, net	`DeferredFinanceCostsNet`	$564.00K	USD	Point-in-time
Series C convertible preferred stock par value	`PreferredStockParOrStatedValuePerShareSeriesC`	$0.00	USD	Point-in-time
Debt issuance costs, net	`DeferredFinanceCostsNet`	-	USD	Point-in-time
Series C convertible preferred stock par value	`PreferredStockParOrStatedValuePerShareSeriesC`	$0.00	USD	Point-in-time
Series C convertible preferred stock shares authorized	`PreferredStockSharesAuthorizedSeriesC`	0.00	shares	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.25M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$485.00K	USD	Point-in-time
Series C convertible preferred stock shares authorized	`PreferredStockSharesAuthorizedSeriesC`	9.00	shares	Point-in-time
TOTAL ASSETS	`Assets`	$3.03M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$2.77M	USD	Point-in-time
Series C convertible preferred stock, Issued	`PreferredStockSharesIssuedSeriesC`	0.00	shares	Point-in-time
Series C convertible preferred stock, Issued	`PreferredStockSharesIssuedSeriesC`	5.90	shares	Point-in-time
Series C convertible preferred stock, Outstanding	`PreferredStockSharesOutstandingSeriesC`	0.00	shares	Point-in-time
Series C convertible preferred stock, Outstanding	`PreferredStockSharesOutstandingSeriesC`	5.90	shares	Point-in-time
Short-term notes payable, including related parties	`ShorttermNotesPayable`	$646.00K	USD	Point-in-time
Short-term notes payable, including related parties	`ShorttermNotesPayable`	$784.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Note payable in default	`NotePayableInDefault`	-	USD	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	195,000.00	shares	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	195,000.00	shares	Point-in-time
Note payable in default	`NotePayableInDefault`	$129.00K	USD	Point-in-time
Current portion of long-term note payable	`ShortTermBorrowings`	-	USD	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	100,055.00	shares	Point-in-time
Current portion of long-term note payable	`ShortTermBorrowings`	$123.00K	USD	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	100,055.00	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	96,889.00	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	96,889.00	shares	Point-in-time
Short-term notes payable, net of discount	`NotesAndLoansPayableCurrent`	$935.00K	USD	Point-in-time
Short-term notes payable, net of discount	`NotesAndLoansPayableCurrent`	$1.06M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.47M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.73M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$1.62M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$1.01M	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$33.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$24.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.60M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.96M	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$1.29M	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$2.07M	USD	Point-in-time
Long-term debt, net	`LongTermDebtNoncurrent`	$40.00K	USD	Point-in-time
Long-term debt, net	`LongTermDebtNoncurrent`	-	USD	Point-in-time
Convertible Debt, net of discount	`ConvertibleLongTermNotesPayable`	$783.00K	USD	Point-in-time
Convertible Debt, net of discount	`ConvertibleLongTermNotesPayable`	-	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$1.29M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$2.89M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$6.25M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$7.50M	USD	Point-in-time
Series B convertible preferred stock, $.001 par value; 3 shares authorized, zero and 1.2 shares issued and outstanding as of September 30, 2015 and December 31, 2014, respectively. (Liquidation preference of zero and $1,200 at September 30, 2015 and December 31, 2014, respectively)	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue`	-	USD	Point-in-time
Series B convertible preferred stock, $.001 par value; 3 shares authorized, zero and 1.2 shares issued and outstanding as of September 30, 2015 and December 31, 2014, respectively. (Liquidation preference of zero and $1,200 at September 30, 2015 and December 31, 2014, respectively)	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue`	$678.00K	USD	Point-in-time
Series C convertible preferred stock, $.001 par value; 9.0 shares authorized, 5.9 shares issued and outstanding as of September 30, 2015 and none authorized or issued and outstanding at December 31, 2014, respectively. (Liquidation preference of $5,894 at September 30, 2015 and none at December 31, 2014)	`SeriesCPreferredStock`	$2.04M	USD	Point-in-time
Series C convertible preferred stock, $.001 par value; 9.0 shares authorized, 5.9 shares issued and outstanding as of September 30, 2015 and none authorized or issued and outstanding at December 31, 2014, respectively. (Liquidation preference of $5,894 at September 30, 2015 and none at December 31, 2014)	`SeriesCPreferredStock`	-	USD	Point-in-time
Common stock, $.001 Par value; 500,000 shares authorized, 143,681 and 96,889 shares issued and outstanding as of September 30, 2015 and December 31, 2014, respectively	`CommonStockValue`	$143.00K	USD	Point-in-time
Common stock, $.001 Par value; 500,000 shares authorized, 143,681 and 96,889 shares issued and outstanding as of September 30, 2015 and December 31, 2014, respectively	`CommonStockValue`	$97.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$114.54M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$107.95M	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-120.08M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-113.06M	USD	Point-in-time
TOTAL STOCKHOLDERS' DEFICIT	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-4.46M	USD	Point-in-time
TOTAL STOCKHOLDERS' DEFICIT	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-3.48M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.03M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$2.77M	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Sales - devices and disposables	`SalesDevicesAndDisposables`	$586.00K	USD	3 Qtrs
Sales - devices and disposables	`SalesDevicesAndDisposables`	$323.00K	USD	3 Qtrs
Sales - devices and disposables	`SalesDevicesAndDisposables`	$262.00K	USD	1 Quarter
Sales - devices and disposables	`SalesDevicesAndDisposables`	$94.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$544.00K	USD	3 Qtrs
Cost of goods sold	`CostOfGoodsSold`	$260.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$230.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$723.00K	USD	3 Qtrs
Gross profit (loss)	`GrossProfit`	$-137.00K	USD	3 Qtrs
Gross profit (loss)	`GrossProfit`	$2.00K	USD	1 Quarter
Gross profit (loss)	`GrossProfit`	$-221.00K	USD	3 Qtrs
Gross profit (loss)	`GrossProfit`	$-136.00K	USD	1 Quarter
Contract and grant revenue	`Revenues`	$22.00K	USD	1 Quarter
Contract and grant revenue	`Revenues`	$8.00K	USD	1 Quarter
Contract and grant revenue	`Revenues`	$33.00K	USD	3 Qtrs
Contract and grant revenue	`Revenues`	$52.00K	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.09M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$892.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.12M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$413.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$187.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$542.00K	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$135.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$762.00K	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.86M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.11M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.55M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.41M	USD	1 Quarter
Total	`OperatingExpenses`	$6.43M	USD	3 Qtrs
Total	`OperatingExpenses`	$2.44M	USD	1 Quarter
Total	`OperatingExpenses`	$1.71M	USD	1 Quarter
Total	`OperatingExpenses`	$4.50M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-1.84M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-2.42M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-4.68M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-6.52M	USD	3 Qtrs
Other income	`OtherIncome`	$14.00K	USD	3 Qtrs
Other income	`OtherIncome`	$69.00K	USD	3 Qtrs
Other income	`OtherIncome`	$10.00K	USD	1 Quarter
Other income	`OtherIncome`	$9.00K	USD	1 Quarter
Changes in fair value of warrants	`DerivativeGainLossOnDerivativeNet`	$-195.00K	USD	1 Quarter
Changes in fair value of warrants	`DerivativeGainLossOnDerivativeNet`	$266.00K	USD	3 Qtrs
Changes in fair value of warrants	`DerivativeGainLossOnDerivativeNet`	$41.00K	USD	1 Quarter
Changes in fair value of warrants	`DerivativeGainLossOnDerivativeNet`	$710.00K	USD	3 Qtrs
Interest expense	`InterestExpense`	$404.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$445.00K	USD	3 Qtrs
Interest expense	`InterestExpense`	$371.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.24M	USD	3 Qtrs
Other income and (expenses)	`OtherNonoperatingIncome`	$-557.00K	USD	1 Quarter
Other income and (expenses)	`OtherNonoperatingIncome`	$-461.00K	USD	3 Qtrs
Other income and (expenses)	`OtherNonoperatingIncome`	$-165.00K	USD	3 Qtrs
Other income and (expenses)	`OtherNonoperatingIncome`	$-353.00K	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.97M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.19M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-6.68M	USD	3 Qtrs
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.14M	USD	3 Qtrs
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	3 Qtrs
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	3 Qtrs
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-5.14M	USD	3 Qtrs
NET LOSS	`NetIncomeLoss`	$-6.68M	USD	3 Qtrs
NET LOSS	`NetIncomeLoss`	$-2.19M	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-2.97M	USD	1 Quarter
PREFERRED STOCK DIVIDENDS AND DEEMED DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$-39.00K	USD	1 Quarter
PREFERRED STOCK DIVIDENDS AND DEEMED DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$-545.00K	USD	1 Quarter
PREFERRED STOCK DIVIDENDS AND DEEMED DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$-1.87M	USD	3 Qtrs
PREFERRED STOCK DIVIDENDS AND DEEMED DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$-128.00K	USD	3 Qtrs
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.01M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.74M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-6.81M	USD	3 Qtrs
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-7.01M	USD	3 Qtrs
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.09	USD	3 Qtrs
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.06	USD	3 Qtrs
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	124,809.00	shares	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	109,902.00	shares	3 Qtrs
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	77,651.00	shares	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	74,052.00	shares	3 Qtrs

Cash Flow Statement 82 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-5.14M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-6.68M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.19M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.97M	USD	1 Quarter
Bad debt expense	`BadDebtExpense`	-	USD	3 Qtrs
Bad debt expense	`BadDebtExpense`	$32.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$359.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$990.00K	USD	3 Qtrs
Stock based compensation	`ShareBasedCompensation`	$852.00K	USD	3 Qtrs
Stock based compensation	`ShareBasedCompensation`	$802.00K	USD	3 Qtrs
Non- employee stock based compensation	`NonEmployeeStockBasedCompensation`	$-400.00K	USD	3 Qtrs
Non- employee stock based compensation	`NonEmployeeStockBasedCompensation`	-	USD	3 Qtrs
Change in fair value of warrants	`ChangeInFairValueOfWarrants`	$301.00K	USD	3 Qtrs
Change in fair value of warrants	`ChangeInFairValueOfWarrants`	$710.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-119.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$316.00K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-268.00K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$11.00K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$497.00K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$330.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$390.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-184.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-267.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$774.00K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$9.00K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-4.00K	USD	3 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$830.00K	USD	3 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$639.00K	USD	3 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$1.88M	USD	3 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$1.55M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-3.59M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-4.81M	USD	3 Qtrs
Additions to fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	$144.00K	USD	3 Qtrs
Additions to fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-144.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.00K	USD	3 Qtrs
Net proceeds from issuance of preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	$3.12M	USD	3 Qtrs
Net proceeds from issuance of preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	-	USD	3 Qtrs
Net proceeds from issuance of common stock and warrants	`ProceedsFromRepurchaseOfEquity`	$720.00K	USD	3 Qtrs
Net proceeds from issuance of common stock and warrants	`ProceedsFromRepurchaseOfEquity`	$201.00K	USD	3 Qtrs
Proceeds from debt financing, net of issuance costs	`ProceedsFromIssuanceOfLongTermDebt`	$4.57M	USD	3 Qtrs
Proceeds from debt financing, net of issuance costs	`ProceedsFromIssuanceOfLongTermDebt`	$415.00K	USD	3 Qtrs
Payments on notes payable	`PaymentsOfLoanCosts`	$459.00K	USD	3 Qtrs
Payments on notes payable	`PaymentsOfLoanCosts`	$789.00K	USD	3 Qtrs
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	$67.00K	USD	3 Qtrs
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	$141.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.60M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.38M	USD	3 Qtrs
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$10.00K	USD	3 Qtrs
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-571.00K	USD	3 Qtrs
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$162.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$172.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$42.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$613.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$162.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$172.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$42.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$613.00K	USD	Point-in-time
Cash paid for Interest	`InterestPaid`	$33.00K	USD	3 Qtrs
Cash paid for Interest	`InterestPaid`	$76.00K	USD	3 Qtrs
Deemed dividend on beneficial conversion feature of Series C preferred stock	`DeemedDividendOnBeneficialConversionFeatureOfSeriesCPreferredStock`	-	USD	3 Qtrs
Deemed dividend on beneficial conversion feature of Series C preferred stock	`DeemedDividendOnBeneficialConversionFeatureOfSeriesCPreferredStock`	$148.00K	USD	3 Qtrs
Deemed dividend on price changes for Series B preferred stock warrants	`DeemedDividendOnPriceChangesForSeriesBPreferredStockWarrants`	-	USD	3 Qtrs
Deemed dividend on price changes for Series B preferred stock warrants	`DeemedDividendOnPriceChangesForSeriesBPreferredStockWarrants`	$64.00K	USD	3 Qtrs
Deemed dividend on December 2014 public offering warrants	`DeemedDividendOnDecember2014PublicOfferingWarrants`	-	USD	3 Qtrs
Deemed dividend on December 2014 public offering warrants	`DeemedDividendOnDecember2014PublicOfferingWarrants`	$1.05M	USD	3 Qtrs
Term changes on Series B preferred stock and December 2014 public offering warrants resulting in transfer to equity	`TermChangesOnSeriesBPreferredStockAndDecember2014PublicOffering`	$1.41M	USD	3 Qtrs
Term changes on Series B preferred stock and December 2014 public offering warrants resulting in transfer to equity	`TermChangesOnSeriesBPreferredStockAndDecember2014PublicOffering`	-	USD	3 Qtrs
Debt issuance cost paid via warrants	`DebtIssuanceCostPaidViaWarrants`	-	USD	3 Qtrs
Debt issuance cost paid via warrants	`DebtIssuanceCostPaidViaWarrants`	$522.00K	USD	3 Qtrs
Issuance of common stock as debt repayment	`IssuanceOfCommonStockAsDebtRepayment`	-	USD	3 Qtrs
Issuance of common stock as debt repayment	`IssuanceOfCommonStockAsDebtRepayment`	$902.00K	USD	3 Qtrs
Issuance of common stock as board compensation	`IssuanceOfCommonStockAsBoardCompensation`	$355.00K	USD	3 Qtrs
Issuance of common stock as board compensation	`IssuanceOfCommonStockAsBoardCompensation`	-	USD	3 Qtrs
Conversion of convertible debt into common stock	`ConversionOfConvertibleDebtIntoCommonStock`	-	USD	3 Qtrs
Conversion of convertible debt into common stock	`ConversionOfConvertibleDebtIntoCommonStock`	$800.00K	USD	3 Qtrs
Conversion of accrued expenses into common stock	`ConversionOfAccruedExpensesIntoCommonStock`	-	USD	3 Qtrs
Conversion of accrued expenses into common stock	`ConversionOfAccruedExpensesIntoCommonStock`	$178.00K	USD	3 Qtrs
Repayment of deferred compensation via issuance of preferred stock	`RepaymentOfDeferredCompensationViaIssuanceOfPreferredStock`	$100.00K	USD	3 Qtrs
Repayment of deferred compensation via issuance of preferred stock	`RepaymentOfDeferredCompensationViaIssuanceOfPreferredStock`	-	USD	3 Qtrs
Dividends on preferred stock	`DividendsOnPreferredStock`	$610.00K	USD	3 Qtrs
Dividends on preferred stock	`DividendsOnPreferredStock`	-	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.